MICA and cancer: For example, a novel CAR targeting the conserved α3 domain of MHC class I chain-related protein A (MICA) and MHC class I chain-related protein B (MICB) is incorporated into a multiplexed-engineered iPSC-derived NK cell exhibiting antigen-specific anti-tumor reactivity across an expansive library of human cancer cell lines [201].